» Articles » PMID: 33042285

Analysis of Mesenchymal Stem Cell Proteomes in the Ischemic Heart

Overview
Journal Theranostics
Date 2020 Oct 12
PMID 33042285
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Cell therapy for myocardial infarction is promising but largely unsuccessful in part due to a lack of mechanistic understanding. Techniques enabling identification of stem cell-specific proteomes in the injured heart may shed light on how the administered cells respond to the injured microenvironment and exert reparative effects. To identify the proteomes of the transplanted mesenchymal stem cells (MSCs) in the infarcted myocardium, we sought to target a mutant methionyl-tRNA synthetase (MetRS) in MSCs, which charges azidonorleucine (ANL), a methionine analogue and non-canonical amino acid, to tRNA and subsequently to nascent proteins, permitting isolation of ANL-labeled MSC proteomes from ischemic hearts by ANL-alkyne based click reaction. Murine MSCs were transduced with lentivirus MetRS and supplemented with ANL; the ANL-tagged nascent proteins were visualized by bio-orthogonal non-canonical amino-acid tagging, spanning all molecular weights and by fluorescent non-canonical amino-acid tagging, displaying strong fluorescent signal. Then, the MetRS-transduced MSCs were administered to the infarcted or Sham heart in mice receiving ANL treatment. The MSC proteomes were isolated from the left ventricular protein lysates by click reaction at days 1, 3, and 7 after cell administration, identified by LC/MS. Among all identified proteins (in Sham and MI hearts, three time-points each), 648 were shared by all 6 groups, accounting for 82±5% of total proteins in each group, and enriched under mitochondrion, extracellular exosomes, oxidation-reduction process and poly(A) RNA binding. Notably, 26, 110 and 65 proteins were significantly up-regulated and 11, 28 and 19 proteins were down-regulated in the infarcted vs. Sham heart at the three time-points, respectively; these proteins are pronounced in the GO terms of extracellular matrix organization, response to stress and regulation of apoptotic process and in the KEGG pathways of complements and coagulation cascades, apoptosis, and regulators of actin cytoskeleton. MetRS expression allows successful identification of MSC-specific nascent proteins in the infarcted hearts, which reflect the functional states, adaptive response, and reparative effects of MSCs that may be leveraged to improve cardiac repair.

Citing Articles

Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy.

Gao S, Li D, Wang B, Zhang H, Chen L Front Cardiovasc Med. 2025; 12:1540066.

PMID: 40046966 PMC: 11880279. DOI: 10.3389/fcvm.2025.1540066.


Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone.

Norton E, Whaley L, Jones V, Brooks M, Russo M, Morderer D Sci Adv. 2024; 10(32):eadn1607.

PMID: 39110807 PMC: 11305394. DOI: 10.1126/sciadv.adn1607.


A mutant methionyl-tRNA synthetase-based toolkit to assess induced-mesenchymal stromal cell secretome in mixed-culture disease models.

Burgess J, Amerna D, Norton E, Parsons T, Perkerson 3rd R, Faroqi A Stem Cell Res Ther. 2023; 14(1):289.

PMID: 37798772 PMC: 10557244. DOI: 10.1186/s13287-023-03515-0.


A Mutant Methionyl-tRNA Synthetase-Based toolkit to assess induced-Mesenchymal Stromal Cell secretome in mixed-culture disease models.

Burgess J, Amerna D, Norton E, Parsons T, Perkerson 3rd R, Faroqi A Res Sq. 2023; .

PMID: 37205579 PMC: 10187403. DOI: 10.21203/rs.3.rs-2838195/v1.


Therapeutic delivery of microRNA-125a-5p oligonucleotides improves recovery from myocardial ischemia/reperfusion injury in mice and swine.

Gao L, Qiu F, Cao H, Li H, Dai G, Ma T Theranostics. 2023; 13(2):685-703.

PMID: 36632217 PMC: 9830430. DOI: 10.7150/thno.73568.


References
1.
Tom Dieck S, Kochen L, Hanus C, Heumuller M, Bartnik I, Nassim-Assir B . Direct visualization of newly synthesized target proteins in situ. Nat Methods. 2015; 12(5):411-4. PMC: 4414919. DOI: 10.1038/nmeth.3319. View

2.
Yun C, Lee S . Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease. Int J Mol Sci. 2019; 20(4). PMC: 6412804. DOI: 10.3390/ijms20040982. View

3.
Prabhu S, Frangogiannis N . The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016; 119(1):91-112. PMC: 4922528. DOI: 10.1161/CIRCRESAHA.116.303577. View

4.
Bai L, Shao H, Wang H, Zhang Z, Su C, Dong L . Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis. Sci Rep. 2017; 7(1):4323. PMC: 5489510. DOI: 10.1038/s41598-017-04559-y. View

5.
Roh J, Sohn D . Damage-Associated Molecular Patterns in Inflammatory Diseases. Immune Netw. 2018; 18(4):e27. PMC: 6117512. DOI: 10.4110/in.2018.18.e27. View